Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease

Medical Journal of Australia

Volumn 186, Issue 2, 2007, Pages 91-94

  Walker, Tim ^a   McCaffery, Joe ^a   Steinfort, Chris ^a  

^a GEELONG HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ATENOLOL; ATORVASTATIN; AZATHIOPRINE; CANDESARTAN; COLCHICINE; DILTIAZEM; ESOMEPRAZOLE; FOSINOPRIL; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITRATE; NITROFURANTOIN; OXYGEN; PRAVASTATIN; PREDNISOLONE; RAMIPRIL; RANITIDINE; SERTRALINE; SIMVASTATIN; THYROXINE; WARFARIN;

AGED; ARTICLE; AWARENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONGESTIVE HEART FAILURE; DEATH; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERSTITIAL LUNG DISEASE; ISCHEMIC HEART DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PEPTIC ULCER; RESPIRATORY FAILURE; STROKE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 33846584122     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb00809.x     Document Type: Article

References (9)

1. Hill C, Zeitz C, Kirkham B. Dermatomyositis with lung involvement in a patient treated with simvastatin. Aust N Z J Med 1995; 25: 745-746.
2. Liebhaber M, Wright R, Gelberg H, et al. Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG-CoA reductase inhibitors: a report of ten cases. Chest 1999; 115: 886-889.
3. De Groot RE, Willems LN, Dijkman JH. Interstitial lung disease with pleural effusion caused by simvastin. J Intern Med 1996; 239: 361-363.
4. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001; 21: 1712-1719.
5. Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 2004; 109 (23 Suppl 1): 11150-11157.
6. Ahmad S. Lovastatin-induced lupus erythematosus. Arch Intern Med 1991; 151: 1667-1668.
7. Bannwarth B, Miremont G, Papapietro PM. Lupuslike syndrome associated with simvastatin. Arch Intern Med 1992; 152: 1093.
8. Fauchais AL, Iba Ba J, Maurage P, et al. [Polymyositis induced or associated with lipid-lowering drugs: five cases] [French]. Rev Med Interne 2004; 25: 294-298.
9. Lantuejoul S, Brambilla E, Brambilla C, Devouassoux G. Statin-induced fibrotic nonspecific interstitial pneumonia. Eur Respir J 2002; 19: 577-580.